Most-Favored Nation Drug Pricing Could Shake Up US Pharma

As part of a broader resurgence in pharmaceutical pricing reform and manufacturing policies in 2025, President Donald Trump and bipartisan congressional leaders have introduced contemporaneous proposals to lower prescription drug prices...

Already a subscriber? Click here to view full article